ES2161146A1 - Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids - Google Patents

Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids

Info

Publication number
ES2161146A1
ES2161146A1 ES9901440A ES9901440A ES2161146A1 ES 2161146 A1 ES2161146 A1 ES 2161146A1 ES 9901440 A ES9901440 A ES 9901440A ES 9901440 A ES9901440 A ES 9901440A ES 2161146 A1 ES2161146 A1 ES 2161146A1
Authority
ES
Spain
Prior art keywords
incorporation
fatty acids
molecular oxygen
antimicrobial compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES9901440A
Other languages
Spanish (es)
Other versions
ES2161146B1 (en
Inventor
Fernandez Carmen Castresana
Herrero Ana Sanz
Mats Hamberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAROLINSKA INST
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
KAROLINSKA INST
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAROLINSKA INST, Consejo Superior de Investigaciones Cientificas CSIC filed Critical KAROLINSKA INST
Priority to ES9901440A priority Critical patent/ES2161146B1/en
Publication of ES2161146A1 publication Critical patent/ES2161146A1/en
Application granted granted Critical
Publication of ES2161146B1 publication Critical patent/ES2161146B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The set of antimicrobial compounds for vegetation comprises the products of the action of protein PIOX. Also claimed is a process utilising the compounds. The process using PIOX, like alpha-dioxygenase, catalyses incorporation of molecular oxygen in various fatty acids (claimed). The compounds act as marker molecules in the activation of specific genes, and have a direct toxic effect on pathogens.
ES9901440A 1999-06-29 1999-06-29 Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids Expired - Fee Related ES2161146B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9901440A ES2161146B1 (en) 1999-06-29 1999-06-29 Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9901440A ES2161146B1 (en) 1999-06-29 1999-06-29 Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids

Publications (2)

Publication Number Publication Date
ES2161146A1 true ES2161146A1 (en) 2001-11-16
ES2161146B1 ES2161146B1 (en) 2002-07-01

Family

ID=8309014

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9901440A Expired - Fee Related ES2161146B1 (en) 1999-06-29 1999-06-29 Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids

Country Status (1)

Country Link
ES (1) ES2161146B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2345241A1 (en) * 2009-03-16 2010-09-17 Lipopharma Therapeutics Use of derivatives of polyunsaturated fatty acids as medicaments
CN109688821A (en) * 2016-09-08 2019-04-26 揖斐电株式会社 The manufacturing method of plant activator and plant activator

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AKIKAZU HATANAKA. THE BIOGENERATION OF GREEN ODOUR BY GREEN LEAVES. Phytochemistry. 1993, Vol. 34, No 5, paginas 1201-1218. *
FARMER, E.E. & RYAN, C.A. Interplant communication: Airborne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves. Proc. Natl. Acad. Sci. USA. Octubre 1990, Vol. 87, paginas 7713-7716. Resumen. *
GALLIARD, T. & MATTHEW, J.A. THE ENZYMIC FORMATION OF LONG CHAIN ALDEHYDES AND ALCOHOLS BY ALPHA-OXIDATION OF FATTY ACIDS IN EXTRACTS OF CUCUMBER FRUIT (CUCUMIS SATIVUS). Biochimia et Biophysica Acta. 1976, Vol. 424, paginas 26-35. Resumen. *
SANZ, A. y col. PIOX, a New Pathogen-Induced Oxygenase with Homology to Animal Cyclooxygenase. The Plant Cell. Septiembre 1998, Vol. 10, paginas 1523-1537. Resumen; discusion. *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2345241A1 (en) * 2009-03-16 2010-09-17 Lipopharma Therapeutics Use of derivatives of polyunsaturated fatty acids as medicaments
WO2010106211A1 (en) * 2009-03-16 2010-09-23 Lipopharma Therapeutics, S.L Use of derivatives of polyunsaturated fatty acids as medicaments
JP2012520344A (en) * 2009-03-16 2012-09-06 リポファーマ セラピューティクス、エス．エル Polyunsaturated fatty acid hydroxy derivatives and their use as drugs
US9161928B2 (en) 2009-03-16 2015-10-20 Lipopharma Therapeutics, S.L. Use of derivatives of polyunsaturated fatty acids as medicaments
US9763906B2 (en) 2009-03-16 2017-09-19 Lipopharma Therapeutics S.L. Use of derivatives of polyunsaturated fatty acids as medicaments
US9763907B2 (en) 2009-03-16 2017-09-19 Lipopharma Therapeutics, S.L. Use of derivatives of polyunsaturated fatty acids as medicaments
US9907772B2 (en) 2009-03-16 2018-03-06 Lipopharma Therapeutics, S.L. Use of derivatives of polyunsaturated fatty acids as medicaments
US10201515B2 (en) 2009-03-16 2019-02-12 Lipopharma Therapeutics, S.L. Use of derivatives of polyunsaturated fatty acids as medicaments
US11253497B2 (en) 2009-03-16 2022-02-22 Lipopharma Therapeutics, S.L. Use of derivatives of polyunsaturated fatty acids as medicaments
CN109688821A (en) * 2016-09-08 2019-04-26 揖斐电株式会社 The manufacturing method of plant activator and plant activator
EP3510868A4 (en) * 2016-09-08 2020-04-08 Ibiden Co., Ltd. Plant activator and process for producing plant activator
US11382281B2 (en) 2016-09-08 2022-07-12 Ibiden Co., Ltd. Plant activator and a method of manufacturing the same

Also Published As

Publication number Publication date
ES2161146B1 (en) 2002-07-01

Similar Documents

Publication Publication Date Title
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
CA2433341A1 (en) Method and system for reducing microbial burden on a food product
AU685673B2 (en) Patch for external use
EP0955044A3 (en) Method of inhibiting bacterial or fungal growth using a complexing agent
ATE273025T1 (en) DHA PHARMACEUTICAL PRODUCT CONJUGATES
BRPI0115953B8 (en) phosphate derivative complexes
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
EP2277549A3 (en) Therapeutic polyanhydride compounds for drug delivery
AU3145995A (en) Indolizine spla2 inhibitors
IL148944A0 (en) Process to separate 1,3-propanediol or gylcerol, or a mixture thereof from a biological mixture
HK1049796A1 (en) Mixture comprising an inhibitor or suppressor of agene and a molecule binding to an expression prod uct of that gene
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU8588898A (en) Composition and process for the treatment of epidermal traumas such as decubitusulcers
WO2001029175A3 (en) Antisense modulation of fra-1 expression
AU2001260077A1 (en) Microfiltration using activated carbon
ES2161146A1 (en) Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids
ATE171620T1 (en) USE OF BRANCH CHAIN AMINO ACIDS FOR PRODUCING A MEDICINAL PRODUCT FOR THE TREATMENT OF TARDIVER DYSKINESIA
ATE234613T1 (en) USE OF COMT INHIBITORS FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR PREVENTING DIABETIC VASCULAR DISORDERS
WO2003040161A3 (en) Antisense modulation of activating transcription factor 3 expression
DE68913128T2 (en) Process for the preparation of L-alanine dehydrogenase and microorganism strain of the genus Sporolactobacillus.
EP0822260A4 (en) Substance fa-70d, process for producing the same, and uses thereof
DE69516162D1 (en) Microbiological process for the preparation of 1-unsaturated, 17-beta-carboxy-substituted 3-oxo-4-azaandrostan-3-ones
ATE320263T1 (en) USE OF HUMAN PROTEIN C FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING HEPARIN-INDUCED THROMBOCYTOPENIA
DE69326050D1 (en) Process for producing 0.0'-diacyltartaric anhydride and process for producing 0.0'-diacyltartaric acid
AU2001262554A1 (en) Inhibiting denaturation of nucleic acid duplexes

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011116

Kind code of ref document: A1

Effective date: 20011116

FD2A Announcement of lapse in spain

Effective date: 20180807